Dare Bioscience, Inc.·4

Jul 2, 4:21 PM ET

RASTETTER WILLIAM H 4

Research Summary

AI-generated summary

Updated

Dare Bioscience (DARE) Director William Rastetter Receives RSU Award

What Happened
William H. Rastetter, a director of Dare Bioscience (DARE), was granted 38,862 restricted stock units (RSUs) on June 30, 2026. The grant is reported at an acquisition price of $0.00 (awarded in lieu of cash compensation); the RSUs are a contingent right to receive one share each when they vest.

Key Details

  • Transaction date: 2026-06-30 (reported on Form 4 filed 2026-07-02).
  • Transaction type/code: Award/Grant (A).
  • Units granted: 38,862 RSUs; reported acquisition price $0.00.
  • Vesting: RSUs vest on January 4, 2027 (per footnote).
  • Shares owned after transaction: not specified in the filing.
  • Footnote: RSUs were granted in lieu of cash compensation for board service; each RSU converts to one share upon vesting.
  • Timeliness: Form 4 filed July 2, 2026. (Form 4s are generally due within two business days of the transaction.)

Context
This was a compensation award, not an open-market purchase or sale, so it reflects pay-for-service rather than a direct insider buy/sell signal. Once the RSUs vest (Jan 4, 2027) they will convert to shares that the director could hold or sell; the filing does not indicate any immediate sale or tax-withholding disposition.